InvestorsHub Logo
Post# of 252525
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 164573

Sunday, 07/28/2013 4:13:31 AM

Sunday, July 28, 2013 4:13:31 AM

Post# of 252525
Re: Musings on Copaxone’s US market share

His figures sound real. I expect the initial negative impact on Copaxon's sales from Tecfidera's extra-forte strong launch to slow (my guess is that NRx is already up a bit from 25%). To what degree depends on how well patients will do on Tecfidera in the long run.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.